We are excited to announce that CARTaGENE will genotype a number of its participants in the upcoming year. This data will become available to the research community with other deeply phenotyped prospective health, physical and biochemical data already collected on 43,000 participants. Some genomic data is already available for access. Please check our website for progress updates and email us for access requests.
CARTaGENE is preparing to conduct its first yearly follow-up survey in mid-2016. Its 43,000 participants will be contacted via a web-portal to update their health status, tell us about recent diagnoses and any other significant changes in their lives. Yearly follow-ups will be conducted on the cohort and this data will be available to the research community. To access this data, researchers are welcome to log onto our sample and data access portal where they can register their project, apply for access and mine the data catalogues.
The CHU Sainte-Justine Hospital has nominated two new Scientific Directors at CARTaGENE. They are Sébastien Jacquemont, MD, a physician researcher specializing in the genetics of neuropsychiatric disorders and Anne-Monique Nuyt, MD, a physician researcher, specializing in oxidative stress in the perinatal period and its effects on cardiovascular health.
For all information:email@example.com
Access all the documents available on our website
TwitterFacebookLinked InGoogle +